HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Izzet Altintas Selected Research

Urokinase Plasminogen Activator Receptors

1/2022Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.
1/2021Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.
11/2020Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Izzet Altintas Research Topics

Disease

3COVID-19
01/2022 - 01/2021
1Thrombophilia
10/2023
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2023
1Venous Thromboembolism
01/2022
1Inflammation (Inflammations)
11/2020

Drug/Important Bio-Agent (IBA)

3Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 11/2020
2Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2021
1fibrin fragment D (D-dimer)IBA
01/2022
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2020

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
01/2021